Ultra Botanica

Ultra Botanica is a biotechnology company focused on enhancing the bioavailability of botanical compounds through its proprietary Liquid Protein Scaffold (LPS) technology. The company specializes in transforming poorly absorbed hydrophobic molecules, such as curcumin, into highly soluble and bioavailable formulations. Their flagship product, UltraCur, is marketed for inflammation and joint health, while the company continues to explore applications in oncology and neurodegenerative diseases. By utilizing protein-binding mechanisms, Ultra Botanica aims to provide pharmaceutical-grade consistency and efficacy in the nutraceutical and botanical medicine space. The company maintains research collaborations with academic institutions to validate the clinical utility of its delivery platform.